Our latest paper titled "A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease" was chosen for APSselect, a collection of the very best original research papers published by the American Physiological Society.

Members of the Thomas Weimbs Lab demonstrate that reducing food intake in mice diminishes the growth of their polycystic kidneys. Read more:

UCSB News Release

The American Physiological Society Press Release

Delivering Drugs to the Right Place

MCDB professor Thomas Weimbs and his team have developed a targeted drug delivery method that could potentially slow the progression of polycystic kidney disease. Weimbs and his team have found a method that enables a class of antibodies, immunoglobulin-A (IgA), to penetrate the cyst walls in PKD kidneys. The strategy opens up the possibility of repurposing a large number of existing drugs for PKD therapy. The researchers’ results appear in the Journal of Biological Chemistry.

Congratulations to Jesse Benza, Elyse Dewey, Claudia Jette, Maddison Kane, Solomiya Kryshtafovych, Katherine Lee, Madelyn Mar, Sirpi Nackeeran, and Pasha Rahbari for each being awarded Undergraduate Research and Creative Activities (URCA) Research Grants to support their research projects in the Weimbs lab. Each award is in the amount of $750.